Submission Planning
- Map the overall registration route and sequence
- Identify key milestones and preparation items
- Form a workable submission plan
For first-time registration of Class II and Class III devices, we provide submission planning, documentation structuring and submission coordination — at a clear, manageable pace.
The chart below shows the official NMPA initial registration process for Class II and III medical devices (including imported products) — six steps from preparation to the registration certificate.
Confirm the management class, compile the product technical requirements, complete product testing and clinical evaluation (or obtain the basis for exemption), and prepare quality management system documents; imported devices must already be authorized for sale in the country of origin.
Domestic Class II devices apply to the provincial medical products administration; Class III devices and imported Class II and III devices apply uniformly to the National Medical Products Administration (NMPA).
The authority conducts a formality review of the dossier.
Conducted by the Center for Medical Device Evaluation and other institutions; where corrections are needed, they are notified once, and the applicant must supply all supplementary materials at once within 1 year of the correction notice; a quality management system audit is carried out where necessary.
The accepting authority decides whether to grant registration within 20 working days of receiving the review opinion.
For approved registrations, the medical device registration certificate is issued, with the approved product technical requirements attached.
Time spent on supplementary materials, QMS audits and expert consultation is not counted in the review timeline; special registration procedures (innovative, priority) have separate provisions. This overview is subject to the latest regulations and the authority's acceptance requirements.
Confirm class and submission route.
Set the preparation and submission plan.
Structure, verify and refine the dossier.
Submit and track through review.
Send us your product information — we will map the submission path and next steps.
Not necessarily — clinical evaluation via predicate data often suffices, and a trial is required only when existing data are insufficient. See our clinical evaluation guide.
Five years from issuance; renew before expiry via renewal service.
NMPA, with technical review by CMDE. The overseas registrant must act through a China agent — see China Agent service.